Quince Therapeutics, Inc. (QNCX) — Financial Flexibility Index
Quince Therapeutics, Inc. (QNCX) has a Financial Flexibility Index of -1.22x as of June 2026. Free cash flow of $-18.89 Million (operating CF $-18.89 Million minus capex $0.00) represents -1% of total liabilities ($15.51 Million). Check how tangible is Quince Therapeutics, Inc.'s equity to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Quince Therapeutics, Inc. Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Quince Therapeutics, Inc. across 9 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Quince Therapeutics, Inc..
Annual Financial Flexibility Index for Quince Therapeutics, Inc. (2017–2025)
Year-by-year free cash flow to debt coverage for Quince Therapeutics, Inc.. Explore debt repayment capacity of Quince Therapeutics, Inc. to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.32x | $-41.07 Million | $-41.42 Million | $129.24 Million | ▲ +15.3% |
| 2024 | -0.38x | $-31.65 Million | $-31.90 Million | $84.33 Million | ▼ -96.9% |
| 2023 | -0.19x | $-18.13 Million | $-18.29 Million | $95.12 Million | ▲ +98.6% |
| 2022 | -13.24x | $-43.91 Million | $-44.04 Million | $3.32 Million | ▼ -208.8% |
| 2021 | -4.29x | $-62.75 Million | $-62.93 Million | $14.64 Million | ▼ -45.2% |
| 2020 | -2.95x | $-50.77 Million | $-50.82 Million | $17.20 Million | ▲ +21.0% |
| 2019 | -3.74x | $-33.22 Million | $-33.28 Million | $8.89 Million | ▲ +52.6% |
| 2018 | -7.88x | $-11.48 Million | $-11.70 Million | $1.46 Million | ▼ -2163.2% |
| 2017 | -0.35x | $-9.75 Million | $-9.83 Million | $28.00 Million | — |